雜志介紹

Journal Of Gastrointestinal Oncology雜志介紹

《Journal Of Gastrointestinal Oncology》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱胃腸腫瘤學(xué)雜志，本刊主要出版、報(bào)道醫(yī)學(xué)-GASTROENTEROLOGY & HEPATOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2，最新CiteScore 指數(shù)為3.2。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• RNA-binding protein ENO1 promotes the tumor progression of gastric cancer by binding to and regulating gastric cancer-related genes

  Author: Wang, Na; Qiao, Hui; Hao, Jianpeng; Deng, Chenghui; Zhou, Nan; Yang, Lei; Zeng, Miaomiao; Guan, Quanlin

• Role of epithelial cell-mesenchymal transition regulators in molecular typing and prognosis of colon cancer

  Author: He, Shengquan; Li, Xiaowen; Zhou, Xindong; Weng, Weiming; Lai, Jiajun

• Immune-related adverse events as independent prognostic factors for camrelizumab in patients with esophageal squamous cell carcinoma: a retrospective cohort study

  Author: Zhao, Ya-Nan; Cong, Dan; Zhang, Wenlong; Jia, Yuanyuan; Bai, Yuansong

• Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study

  Author: Huang, Xiao; Zhou, Yiming; Zang, Yiwen; Yang, Yi; Wang, Zihao; Chen, Zongyou; Gu, Xiaodong; Zhang, Jian; Xiang, Jianbin

英文介紹

Journal Of Gastrointestinal Oncology雜志英文介紹

ournal of Gastrointestinal Oncology (Print ISSN 2078-6891; Online ISSN 2219-679X; J Gastrointest Oncol; JGO), the official journal of Society for Gastrointestinal Oncology (SGO), is an open-access, international peer-reviewed journal. It is published quarterly (Sep. 2010- Dec. 2013), bimonthly (Feb. 2014 -) and openly distributed worldwide.

JGO publishes manuscripts that focus on updated and practical information about diagnosis, prevention and clinical investigations of gastrointestinal cancer treatment. Specific areas of interest include, but not limited to, multimodality therapy, markers, imaging and tumor biology.